BMO Capital Markets assumed coverage on shares of Avidity Biosciences (NASDAQ:RNA – Free Report) in a research note issued to ...

Investment analysts at Citigroup began coverage on shares of Avidity Biosciences (NASDAQ:RNA – Get Free Report) in a research ...

Researchers at Case Western Reserve University have discovered molecules that present the potential to drive the development ...

Fintel reports that on March 13, 2025, Citigroup initiated coverage of Avidity Biosciences (NasdaqGM:RNA) with a Buy ...

Our DNA is constantly under threat — from cell division errors to external factors like sunlight and smoking. Fortunately, ...

A new study from Memorial Sloan Kettering Cancer Center has shown that an RNA-based neoantigen vaccine can generate ...

For the Liu Lab, necessity is truly the mother of invention. The researchers were examining how the 3D organization of the ...

This listicle explores four major RNA therapeutic modalities, highlighting their breakthroughs, challenges and future ...

Researchers at The Jackson Laboratory and UConn Health discovered that cancer cells suppress "poison exons" — genetic ...

Pheiron and Ribo are excited to announce that the first two strategic collaboration milestones have been successfully ...

The RNA inhibitor reduces levels of oxidized phospholipids, which are presumed to promote atherosclerosis, by more than 93%.

ViiV Healthcare's EMBRACE study shows VH109 with CAB LA effectively suppresses HIV. The company also reports promising early ...